(19)
(11) EP 0 836 617 A1

(12)

(43) Date of publication:
22.04.1998 Bulletin 1998/17

(21) Application number: 96923662.0

(22) Date of filing: 03.07.1996
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A01N 63/ 00( . )
A61L 12/ 14( . )
A61P 31/ 04( . )
C07K 7/ 08( . )
C12N 1/ 20( . )
C12P 21/ 08( . )
A01N 37/ 46( . )
A61K 38/ 00( . )
A61P 1/ 02( . )
A61P 31/ 12( . )
C07K 16/ 00( . )
C12P 21/ 02( . )
(86) International application number:
PCT/US1996/011323
(87) International publication number:
WO 1997/002287 (23.01.1997 Gazette 1997/05)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 06.07.1995 US 19950000898P

(71) Applicant: Intrabiotics Pharmaceuticals, Incorporated
Sunnyvale, CA 94086 (US)

(72) Inventors:
  • LEHRER, Robert, I.
    Santa Monica, CA 90403 (US)
  • HARWIG, Sylvia, S., L.
    Woodland Hills, CA 91364 (US)
  • CHANG, Conway, Cheng
    San Francisco, CA 94110 (US)
  • GU, Chee, Liang
    Saratoga, CA 95070 (US)

(74) Representative: Horner, Martin Grenville, et al 
Cruikshank & Fairweather 19 Royal Exchange Square
Glasgow G1 3AE Scotland
Glasgow G1 3AE Scotland (GB)

   


(54) PAREVINS AND TACHYTEGRINS